139 related articles for article (PubMed ID: 3039783)
1. Proliferative potential of vascular components in human glioblastoma multiforme.
Nagashima T; Hoshino T; Cho KG
Acta Neuropathol; 1987; 73(3):301-5. PubMed ID: 3039783
[TBL] [Abstract][Full Text] [Related]
2. Pediatric central nervous system tumors: a cell kinetic study with bromodeoxyuridine.
Murovic JA; Nagashima T; Hoshino T; Edwards MS; Davis RL
Neurosurgery; 1986 Dec; 19(6):900-4. PubMed ID: 3027608
[TBL] [Abstract][Full Text] [Related]
3. The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling.
Nagashima T; Hoshino T; Cho KG; Edwards MS; Hudgins RJ; Davis RL
Cancer; 1988 Jun; 61(12):2433-8. PubMed ID: 3284636
[TBL] [Abstract][Full Text] [Related]
4. Variability in the proliferative potential of human gliomas.
Hoshino T; Nagashima T; Cho KG; Davis RL; Donegan J; Slusarz M; Wilson CB
J Neurooncol; 1989 Jul; 7(2):137-43. PubMed ID: 2550593
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of bromodeoxyuridine labeling in primary and recurrent glioblastoma multiforme.
Ritter AM; Sawaya R; Hess KR; Levin VA; Bruner JM
Neurosurgery; 1994 Aug; 35(2):192-8; discussion 198. PubMed ID: 7969825
[TBL] [Abstract][Full Text] [Related]
6. [A cell kinetic study of human central nervous system tumors with 5-bromodeoxyuridine (BrdU)].
Nagashima T; Hoshino T
No To Shinkei; 1985 Dec; 37(12):1195-201. PubMed ID: 3912000
[TBL] [Abstract][Full Text] [Related]
7. A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.
Sharma S; Karak AK; Singh R; Mehta VS; Sarkar C; Schmitt HP
Pathol Oncol Res; 1999; 5(2):134-41. PubMed ID: 10393366
[TBL] [Abstract][Full Text] [Related]
8. Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine.
Hoshino T; Nagashima T; Murovic JA; Wilson CB; Davis RL
Cancer; 1986 Oct; 58(7):1466-72. PubMed ID: 2427189
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical study of S-phase cells in human gliomas].
Ibayashi N; Hirakawa K; Suzuki K; Nakamura K; Houri T
No To Shinkei; 1988 Aug; 40(8):763-9. PubMed ID: 2460117
[TBL] [Abstract][Full Text] [Related]
10. Proliferative potential and outcome in pediatric astrocytic tumors.
Prados MD; Krouwer HG; Edwards MS; Cogen PH; Davis RL; Hoshino T
J Neurooncol; 1992 Jul; 13(3):277-82. PubMed ID: 1325544
[TBL] [Abstract][Full Text] [Related]
11. The proliferative activity of neurilemomas.
Lee KS; Nagashima T; Cho KG; Mampalam TJ; Pitts LH; Hoshino T
Surg Neurol; 1989 Dec; 32(6):427-33. PubMed ID: 2700052
[TBL] [Abstract][Full Text] [Related]
12. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.
Morimura T; Kitz K; Budka H
Acta Neuropathol; 1989; 77(3):276-82. PubMed ID: 2922990
[TBL] [Abstract][Full Text] [Related]
13. Proliferative characteristics of juvenile pilocytic astrocytomas determined by bromodeoxyuridine labeling.
Ito S; Hoshino T; Shibuya M; Prados MD; Edwards MS; Davis RL
Neurosurgery; 1992 Sep; 31(3):413-8; discussion 419. PubMed ID: 1407423
[TBL] [Abstract][Full Text] [Related]
14. Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors.
Iwata S; Nakagawa K; Harada H; Oka Y; Kumon Y; Sakaki S
Neurosurgery; 1999 Jul; 45(1):24-8; discussion 29. PubMed ID: 10414562
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues.
Nagashima T; DeArmond SJ; Murovic J; Hoshino T
Acta Neuropathol; 1985; 67(1-2):155-9. PubMed ID: 2992212
[TBL] [Abstract][Full Text] [Related]
16. Proliferative activity of microvascular cells in glioblastomas does not correlate with time to recurrence.
Kern MA; Feisel KD; Friese M; Ernestus RI; Schröder R
J Neurooncol; 2003 May; 63(1):9-13. PubMed ID: 12814249
[TBL] [Abstract][Full Text] [Related]
17. S-phase fraction of human brain tumors in situ measured by uptake of bromodeoxyuridine.
Hoshino T; Nagashima T; Cho KG; Murovic JA; Hodes JE; Wilson CB; Edwards MS; Pitts LH
Int J Cancer; 1986 Sep; 38(3):369-74. PubMed ID: 3527993
[TBL] [Abstract][Full Text] [Related]
18. Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells.
Pallini R; Pierconti F; Falchetti ML; D'Arcangelo D; Fernandez E; Maira G; D'Ambrosio E; Larocca LM
J Neurosurg; 2001 Jun; 94(6):961-71. PubMed ID: 11409526
[TBL] [Abstract][Full Text] [Related]
19. Bromodeoxyuridine labeling index in glioblastoma multiforme: relation to radiation response, age, and survival.
Barker FG; Prados MD; Chang SM; Davis RL; Gutin PH; Lamborn KR; Larson DA; McDermott MW; Sneed PK; Wilson CB
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):803-8. PubMed ID: 8598356
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of factor VIII/von Willebrand factor in hyperplastic endothelial cells in glioblastoma multiforme and mixed glioma-sarcoma.
McComb RD; Jones TR; Pizzo SV; Bigner DD
J Neuropathol Exp Neurol; 1982 Sep; 41(5):479-89. PubMed ID: 6286891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
